Shannon - your story sounds like mine. See below.
I'm on the herceptin clinical trial in a herceptin arm. While we know herceptin won't prevent mets, there is good evidence it might help decrease recurrance. Look for the MD Anderson study where they now give herceptin to ALL stage I-III patients who are her2+ (June 04). Bring that to your onc and really push if you think it's the right decision for you.
Best of luck - Rose
Dx'd 1/04 at 33, while 33 weeks pregnant (baby devliered at 35 weeks and is now >100% in weight %)!
Dx: Stage IIIC IDC, ER-, PR+ (23%), Her2=2.7, 2.5cm primary tumor, grade III, 11/18+ nodes (largest 3.8 cm)
Treatment: A/C *4, T *4, 1 year of herceptin, mastectomy, rads (7 weeks), tamoxifen and zoladex (5 years)
|